Singapore: Biotech Epicenter in Asia with Opportunities for Spain

With a unique combination of institutional stability, high public investment in R&D, and a highly sophisticated business ecosystem, Singapore has established itself as one of Asia's leading bioclusters. It is currently positioned as a strategic market for the healthcare and biotechnology sectors. Initiatives such as the Research, Innovation and Enterprise 2025 plan, which has allocated more than SGD 25 billion to key sectors like biotechnology, and the creation of the Biopolis scientific hub, have been instrumental in this development.

The country stands out particularly in red biotechnology, with multinational companies such as Pfizer, GSK, and Johnson & Johnson already established there, alongside a growing ecosystem of startups and local investment. In recent years, Singapore has tripled its pharmaceutical production and doubled its specialized workforce. Added to this is an increasing demand for healthcare driven by an aging population, with projections placing healthcare spending above SGD 42 billion by 2028.

For Spanish companies, this context presents a tangible opportunity. Spain is already Singapore’s sixth-largest biotech supplier, and companies such as Grifols, Reig Jofre, and PharmaMar have begun to establish a presence or distribute their products in the region. ICEX has identified Singapore not only as an attractive market on its own, but also as a strategic gateway to Southeast Asia, where a growing middle class and expanding healthcare sector are transforming demand.

ICEX encourages Spanish biotech companies to explore this high-potential ecosystem. Our Economic and Commercial Office of Spain in Singapore has developed a specialized document titled Biotechnology in Singapore report, which offers essential insights and key information for companies interested in this market.

In addition, ICEX and the Economic and Commercial Office of Spain in Singapore provide personalized services to ease market entry, connect with distributors or local partners, and prepare tailored business agendas according to each company's profile. Betting on Singapore means betting on innovation, international expansion, and long-term competitiveness.

If you want to learn more about everything ICEX designs and develops to support the international growth of startups and tech companies worldwide, contact our team of experts, and they will offer you personalized advice.